Kosin University Gospel Hospital
32
4
5
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
3.1%
1 terminated/withdrawn out of 32 trials
94.1%
+7.6% vs industry average
34%
11 trials in Phase 3/4
0%
0 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (32)
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Role: collaborator
Oncometabolic Surgery
Role: collaborator
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Role: collaborator
Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)
Role: collaborator
RCT of Gastric ESD With or Without Epineprhine Added Solution
Role: collaborator
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Role: collaborator
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Role: collaborator
FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease
Role: collaborator
Resting Full-cycle Ratio (RFR)-Guided Revascularization
Role: collaborator
R-VRD Followed by Lenalidomide Maintenance in Patients With Waldenstrom's Macroglobulinemia
Role: lead
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone
Role: lead
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma
Role: collaborator
Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)
Role: collaborator
Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
Role: lead
Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung
Role: collaborator
Comparison of Treatment Outcome and Cost-effectiveness for GERD
Role: collaborator
The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)
Role: lead
Erythropoietin for Management of Anemia Caused by Chemotherapy
Role: lead
The Change of Gut Microbiota After Bowel Preparation and the Effect of Probiotics
Role: lead
Comparison of Biomatrix and Orsiro Drug Eluting Stent
Role: collaborator